G1 Therapeutics, Inc.·4

Oct 5, 6:04 PM ET

Strum Jay 4

4 · G1 Therapeutics, Inc. · Filed Oct 5, 2018

Insider Transaction Report

Form 4
Period: 2018-10-04
Strum Jay
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-10-0485015,816 total
    Exercise: $0.30Exp: 2022-11-09Common Stock (850 underlying)
  • Exercise/Conversion

    Common Stock

    2018-10-04$0.30/sh+850$25549,419 total
Footnotes (1)
  • [F1]All shares underlying this option have vested.

Documents

2 files